Salidroside alleviates oxidative stress in dry eye disease by activating autophagy through AMPK-Sirt1 pathway
International Immunopharmacology · 2023
DOI: 10.1016/j.intimp.2023.110397 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Qi Liang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Affiliated Drum Tower Hospital, Medical School, Nanjing University, 321 Zhongshan Rd, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Antioxidants, AMP-Activated Protein Kinases. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Nanjing University.
Abstract (Originalsprache)
Dry eye disease (DED) is a multifactorial disease, and oxidative stress plays a crucial role in its pathogenesis. Recently, multiple studies have shown that upregulation of autophagy can protect the cornea from oxidative stress damage. The present study investigated the therapeutic effects of salidroside, the main component of Rhodiola crenulata, in both in vivo and in vitro dry eye models. The results showed that topical eye drop treatment with salidroside restored corneal epithelium damage, increased tear secretion, and reduced cornea inflammation in the DED mice. Salidroside activated autophagy through AMP-activated protein kinase (AMPK)-sirtuin-1 (Sirt1) signaling pathway, which promoted the nuclear translocation of nuclear factor erythroid-2-related factor 2 (Nrf2) and increased the expression of downstream antioxidant factors heme oxygenase-1 (HO-1) and NAD(P)H quinone dehydrogenase 1 (NQO1). This process restored antioxidant enzyme activity, reduced reactive oxygen species (ROS) accumulation, and alleviated oxidative stress. The application of autophagy inhibitor chloroquine and AMPK inhibitor Compound C reversed the therapeutic efficacy of salidroside, validating the above findings. In conclusion, our data suggest that salidroside is a promising candidate for DED treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Affiliated Drum Tower Hospital, Medical School, Nanjing University, 321 Zhongshan Rd, Nanjing, Jiangsu, China.
- National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, 618 Fengqi East Rd, Hangzhou, Zhejiang, China.
- Department of Ophthalmology, Affiliated Drum Tower Hospital, Medical School, Nanjing University, 321 Zhongshan Rd, Nanjing, Jiangsu, China; Department of Rheumatology and Immunology, Affiliated Drum Tower Hospital, Medi…
- Department of Neurosurgery, Affiliated Drum Tower Hospital, Medical School, Nanjing University, 321 Zhongshan Rd, Nanjing, Jiangsu, China. Electronic address: yuett0918@163.com.
- Department of Ophthalmology, Affiliated Drum Tower Hospital, Medical School, Nanjing University, 321 Zhongshan Rd, Nanjing, Jiangsu, China. Electronic address: kai_hu@nju.edu.cn.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Nanjing University
Zitieren
APA
Liang, Q., Guo, R., Tsao, J. R., He, Y., Wang, C., Jiang, J., Zhang, D., Chen, T., Yue, T., & Hu, K. (2023). Salidroside alleviates oxidative stress in dry eye disease by activating autophagy through AMPK-Sirt1 pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110397
Vancouver
Liang Q, Guo R, Tsao JR, He Y, Wang C, Jiang J, et al. Salidroside alleviates oxidative stress in dry eye disease by activating autophagy through AMPK-Sirt1 pathway. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110397
BibTeX
@article{Liang2023,
author = {Liang, Qi and Guo, Rongjie and Tsao, Jia-Ruei and He, Yun and Wang, Chenchen and Jiang, Jiaxuan and Zhang, Di and Chen, Taige and Yue, Tingting and Hu, Kai},
title = {Salidroside alleviates oxidative stress in dry eye disease by activating autophagy through AMPK-Sirt1 pathway},
journal = {International Immunopharmacology},
year = {2023},
doi = {10.1016/j.intimp.2023.110397}
}
EUVIMED